Antisense Bcl-2 gene therapy
Latest Information Update: 14 Jan 2003
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Gene therapies
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bladder cancer
Most Recent Events
- 14 Jan 2003 No development reported - Preclinical for Bladder cancer in United Kingdom (unspecified route)
- 19 Jan 2001 Preclinical development for Bladder cancer in United Kingdom (Unknown route)